Studi Penggunaan Antidislipidemia Pada Pasien Stroke Iskemik (Penelitian dilakukan di RSUD R.T. Notopuro Sidoarjo)
Abstract
Stroke is a neurologic deficit resulting from damage to the brain due to disruption of blood flow that occurs suddenly and rapidly. 87% of strokes are ischemic strokes, caused by a lack of oxygen supply to the brain due to embolism, thrombus or atherosclerosis. Blockage of blood flow will disrupt cell function accompanied by necrosis which can then lead to infarction. Antidyslipidemia is given to all ischemic stroke patients as secondary therapy and prevention of recurrent stroke. The use of Antidyslipidemia in ischemic stroke patients improves lipid abnormalities, reduces the occurrence of coronary heart disease, and improves clinical outcomes. This study aim to describe the use pattern of antidyslipidemia in ischemic stroke patients at RSUD R.T. Notopuro Sidoarjo. The type of this research is observational research with retrospective data collection method for the period October 2023 - December 2023 and then analyzed descriptively. The pattern of antidyslipidemia use is a single use pattern, as many as 78 patterns (99%). The most common single use pattern was given atorvastatin (1 x 20 mg) as many as 66 patients (86%). The combination usage pattern given was atorvastatin (1 x 20 mg) po + fenofibrate (1 x 300 mg). The switching use pattern of atorvastatin (1 x 40 mg)po > atorvastatin (1 x 20 mg)po was given to 1 patient.
Keywords
Full Text:
PDFReferences
Kemenkes RI, "STROKE" Kementerian Kesehatan Direktorat Jenderal Pelayanan Kesehatan RI. Accessed: Jan. 16, 2024. [Online]. Available: https://yankes.kemkes.go.id/view_artikel/620/stroke
A. K. Boehme, C. Esenwa, and M. S. V. Elkind, "Stroke Risk Factors, Genetics, and Prevention" Feb. 03, 2017, Lippincott Williams and Wilkins. doi: 10.1161/CIRCRESAHA.116.308398.
Kementerian Kesehatan RI Badan Penelitian dan Pengembangan Kesehatan, "Laporan Nasional RISKESDAS 2018" 2018.
T. E. Nogles and M. A. Galuska, "Stroke Arteri Serebral Tengah." Accessed: Dec. 15, 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK556132/
Azzahra Sahla Delia and Fitriyani, "LAPORAN KASUS : STROKE NON HEMORAGIK" 2023.
S. E. Mutiari, R. L. D. Dyan, and M. Zakiah, "Hubungan antara Nilai Hematokrit dan Early Neurological Deterioration pada Pasien Stroke Iskemik Akut" 2019.
R. Suhadi, P. Hendra, D. M. Virginia, C. H. Setiawan, and Y. Linawati, Seluk-Beluk Hiperlipidemia: Peningkatan Partisipasi dan Kompetensi Farmasis dalam Pencegahan Penyakit Kardiovaskular. 2018.
American Stroke Associaton, "Stroke" American Stroke Associaton. Accessed: Jan. 16, 2024. [Online]. Available: https://www.stroke.org/en/
D. Anggita and Adnan, "ANALISIS HUBUNGAN TERAPI ANTIHIPERLIPIDEMIA SEBAGAI PENCEGAHAN SEKUNDER TERHADAP SERANGAN ULANG PADA PASIEN STROKE ISKEMIK ANALYSIS OF THE CORRELATION OF ANTI HYPERLIPIDEMIA THERAPY AS A SECONDARY PREVENTION OF ISCHEMIC STROKE RECURRENT IN ISCHEMIC STROKE PATIENTS" 2023.
K. Malekmohammad, E. E. Bezsonov, and M. Rafieian-Kopaei, "Role of lipid accumulation and inflammation in atherosclerosis: Focus on molecular and cellular mechanisms" 2021, Frontiers Media S.A. doi: 10.3389/fcvm.2021.707529.
S. Jebari-Benslaiman et al., "Pathophysiology of Atherosclerosis" Mar. 01, 2022, MDPI. doi: 10.3390/ijms23063346.
B. Udin and E. Kholifah, "Literature Review: Mekanisme Kerja Obat Antidislipidemia" 2021.
Y. J. Lee et al., "Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial" BMJ (Clinical research ed.), vol. 383, p. e075837, Oct. 2023, doi: 10.1136/bmj-2023-075837.
S. Ihsan, M. Leorita, and I. Y. Daud, "Efektivitas Terapi Statin pada Pasien Pasca Stroke Iskemik (Effectiveness of Statin Therapy in Ischemic Post Stroke Patients)" Pharmauho: Jurnal Farmasi, vol. 6, no. 1, pp. 27-32, 2020, doi: 10.33772/pharmauho.v6i.
H. Abdu and G. Seyoum, "Sex Differences in Stroke Risk Factors, Clinical Profiles, and In-Hospital Outcomes Among Stroke Patients Admitted to the Medical Ward of Dessie Comprehensive Specialized Hospital, Northeast Ethiopia" Degenerative Neurological and Neuromuscular Disease, vol. Volume 12, pp. 133-144, Oct. 2022, doi: 10.2147/dnnd.s383564.
L. Hairani, "PERBANDINGAN KADAR PROFIL LIPID PADA PASIEN STROKE ISKEMIK DENGAN STROKE HEMORAGIK DI RSUD BUDHI ASIH JAKARTA TIMUR TUGAS AKHIR" 2022.
A. M. Huda, A. Mustofa, and S. Roekminiati, "Kualitas Pelayanan Kesehatan Program JKMM (Jaminan Kesehatan Masyarakat Miskin)Pasien IGD Rawat Inap di RSU Anwar Medika Sidoarjo" 2023.
M. A. Jacob et al., "Global Differences in Risk Factors, Etiology, and Outcome of Ischemic Stroke in Young Adults-A Worldwide Meta-analysis" Neurology, vol. 98, no. 6, pp. E573-E588, Feb. 2022, doi: 10.1212/WNL.0000000000013195.
Y. Pan et al., "LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA" Stroke and vascular neurology, vol. 7, no. 4, pp. 276-284, Aug. 2022, doi: 10.1136/svn-2021-001317.
W. D. Latif, M. Aswad, and Muh. A. Bahar, "Perbandingan Efektivitas Klinik Simvastatin dan Atorvastatin Terhadap Profil Lipid Darah: Studi Kasus di Rumah Sakit Universitas Hasanuddin" Jurnal Sains Farmasi & Klinis, vol. 9, no. 1, p. 34, Jul. 2022, doi: 10.25077/jsfk.9.1.34-41.2022.
G. Stillemans et al., "Atorvastatin population pharmacokinetics in a real-life setting: Influence of genetic polymorphisms and association with clinical response" Clinical and Translational Science, vol. 15, no. 3, pp. 667-679, Mar. 2022, doi: 10.1111/cts.13185.
E. Climent, D. Benaiges, and J. Pedro-Botet, "Hydrophilic or Lipophilic Statins?" 2021, Frontiers Media SA. doi: 10.3389/fcvm.2021.687585.
F. A. Lagunas-Rangel et al., "Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases" 2024, John Wiley and Sons Inc. doi: 10.1111/bph.17309.
H. M. Fan et al., "Intensive Versus Moderate Statin-Based Therapies in Patients With Mild Ischemic Stroke: A Prospective Multicenter Cohort Study" Journal of the American Heart Association, vol. 13, no. 14, p. e035337, Jul. 2024, doi: 10.1161/JAHA.124.035337.
A. M. A. M et al., "Panduan Pengelolaan Dislipidemia di Indonesia 2021" 2021.
M. S. Park et al., "Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study" Clinical Therapeutics, vol. 43, no. 10, pp. 1735-1747, Oct. 2021, doi: 10.1016/j.clinthera.2021.08.005.
Deepak Gunwal, Braham Dutt, Manjusha Choudhary, and Vikas Budhwar, "A Comprehensive Review on the Drug: Fenofibrate" International Journal of Research in Pharmaceutical Sciences, vol. 12, no. 3, pp. 2164-2172, Aug. 2021, doi: 10.26452/ijrps.v12i3.4829.
V. Kytö, J. Åivo, and J. O. Ruuskanen, "Intensity of statin therapy after ischaemic stroke and long-term outcomes: A nationwide cohort study" Stroke and Vascular Neurology, 2024, doi: 10.1136/svn-2024-003230.
D. Wang, B. Liu, W. Tao, Z. Hao, and M. Liu, "Fibrates for secondary prevention of cardiovascular disease and stroke" Oct. 25, 2015, John Wiley and Sons Ltd. doi: 10.1002/14651858.CD009580.pub2.
S. H. Jo, H. Nam, J. Lee, S. Park, J. Lee, and D. S. Kyoung, "Fenofibrate Use Is Associated With Lower Mortality and Fewer Cardiovascular Events in Patients With Diabetes: Results of 10,114 Patients From the Korean National Health Insurance Service Cohort" Diabetes Care, vol. 44, no. 8, pp. 1868-1876, Aug. 2021, doi: 10.2337/DC20-1533.
N. Syifa', C. Dwi, and D. Hasmono, "Drug Utilization Study of Statin in Hemorrhagic Stroke" 2017.
M. Arfania, D. Frianto, R. Marsada Ukur Ujung, and Z. Fatiha Nurulhadi, "LITERARATURE REVIEW : Peran Obat Golongan Statin Terhadap Pasien Stroke Iskemik Berulang" Journal Of Social Science Research, vol. 3, 2023.
R. Purnamasari, M. A. Manggau, and M. Yunus Amran, "HUBUNGAN ANTARA PENGGUNAAN OBAT ATORVASTATIN TERHADAP PERBAIKAN KLINIS PASIEN STROKE ISKEMIK DI RSUP DR. WAHIDIN SUDIROHUSODO" 2018.
I. Fahmi Almuhtarihan, J. Setiawan Irianto, D. Hasmono, and N. Syifa', "PHARMASIPHA : Pharmaceutical Journal of Islamic Pharmacy Studi pola administrasi penggunaan asetosal pada pasien stroke iskemik Pattern administration study of asetosal in stroke ischaemic patient" vol. 8, no. 1, 2024, doi: 10.21111/pharmasipha.v8i1.
D. S. Praja, D. Hasmono, and N. Syifa, "STUDI PENGGUNAAN OBAT NEUROPROTEKTAN PADA PASIEN STROKE ISKEMIK(Penelitian Di Rumah Sakit Umum Dr. Saiful Anwar Malang)" Dec. 2013.
DOI: https://doi.org/10.37311/ijpe.v4i3.29326
Refbacks
- There are currently no refbacks.
Copyright (c) Nailis Syifa
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.